17th Annual Holiday Rock & Roll Bash Raises More Than $800,000 for the Lustgarten Foundation
December 14 2017 - 10:00AM
All Money Raised Goes Directly to
Pancreatic Cancer Research
On Wednesday evening, December 13, The Madison Square Garden
Company (NYSE:MSG) and AMC Networks (NASDAQ:AMCX) hosted the 17th
Annual Holiday Rock & Roll Bash to benefit the Lustgarten
Foundation, the nation’s largest private funder of pancreatic
cancer research. The Bash is the Foundation’s premier fundraising
event, and this year, raised more than $800,000. Thanks to private
funding, 100 percent of every dollar raised goes directly to
pancreatic cancer research.
Entertainment for the event, held at Tao Downtown in New York
City, included a special DJ set from Grammy Award winning music
producer and recording artist Swizz Beatz, along with an exclusive
performance from the Christmas Spectacular by the world-famous
Radio City Rockettes.
“Over the past 17 years, the Bash has raised more than $23
million to further our goal of ending pancreatic cancer,” said
Kerri Kaplan, president and chief executive officer of the
Lustgarten Foundation. “The only way to achieve that goal is
through research, and we have the most talented researchers
diligently working on earlier detection methods and more effective
treatments. We are incredibly grateful to MSG and AMC Networks for
supporting us in this mission, and putting on this outstanding
fundraising event.”
There has never been a more exciting time in pancreatic cancer
research. Earlier this year, in an unprecedented, fast-tracked
review, the Food and Drug Administration (FDA) approved
pembrolizumab (Keytruda®) as the first immunotherapy treatment for
advanced pancreatic cancer patients whose tumors are mismatch
repair deficient. It is estimated that approximately 1 in 50
advanced pancreatic cancer patients have tumors that are mismatch
repair deficient. The Lustgarten Foundation played a critical role
in bringing Keytruda to pancreatic cancer patients by funding this
innovative research, encouraging patients to get their tumors
tested, and covering the cost of the test.
However, there is still much work to be done. Pancreatic cancer
is swift and silent, and often undetected until it is too late. The
overall five-year survival rate is still only eight percent and
most with advanced pancreatic cancer die within a year. It is the
third-leading cause of cancer deaths in the United States.
The Lustgarten Foundation was established in 1998 to honor Marc
Lustgarten, who served as the former vice chairman of Cablevision
Systems Corporation and chairman of Madison Square Garden, before
he died from pancreatic cancer. James Dolan, executive chairman and
chief executive officer of The Madison Square Garden Company and
former chief executive officer of Cablevision; and Charles Dolan,
executive chairman of AMC Networks and former chairman of
Cablevision, helped establish the Foundation, and have been closely
involved in supporting its mission to advance pancreatic cancer
research and paying homage to Mr. Lustgarten’s legacy.
About The Lustgarten Foundation
The Lustgarten Foundation is America's largest private
foundation dedicated to funding pancreatic cancer research. Based
in Woodbury, NY, the Foundation supports research to find a cure
for pancreatic cancer. Since its inception, the Lustgarten
Foundation has directed $132 million to research. For
more information, please visit www.lustgarten.org.
Contacts:
Mikyl CordovaThe Madison Square Garden
Company212-631-4337Mikyl.cordova@msg.com
AMC Networks (NASDAQ:AMCX)
Historical Stock Chart
From Aug 2024 to Sep 2024
AMC Networks (NASDAQ:AMCX)
Historical Stock Chart
From Sep 2023 to Sep 2024